We then intersected these AR-targeted enhancer peaks with highly expressed genes in DSRCT (Fig. 8c and Supplemental Data 2) (FC > 1.5, adjusted p value < 0.05 in comparison to other sarcoma subtypes). The gene discussed is AR; the disease is sarcoma.